homovanillic acid has been researched along with neuropeptide y in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 11 (68.75) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berrettini, WH; Cohen, RM; Lawlor, BA; Martinez, RA; Molchan, SE; Sunderland, T; Tariot, PN; Vitiello, B | 1 |
| Beal, MF; Ellison, DW; Frank, RC; Martin, JB | 1 |
| Hastings, JA; Morris, MJ; Pavia, JM | 2 |
| Beal, MF; Brouillet, E; Henshaw, DR; Hyman, BT; Jenkins, BG; Rosen, BR; Schulz, JB; Sodhi, P | 1 |
| Bouali, SM; Drumheller, A; Fournier, A; Jolicoeur, FB; St-Pierre, S | 1 |
| Beal, MF; Brouillet, E; Ferrante, RJ; Hyman, BT; Jenkins, BG; Kowall, NW; Miller, JM; Rosen, BR; Srivastava, R; Storey, E | 1 |
| Braas, KM; Brandenburg, CA; May, V | 1 |
| Feth, F; Hunneman, DH; Kremens, B; Lang, RE; Rascher, W; Wagner, S | 1 |
| Halmi, KA | 1 |
| Björntorp, P; Blennow, K; Ekman, R; Krotkiewski, M; Månsson, JE; Strömbom, U | 1 |
| Guss, V; Korpinen, C; Matos, FF | 1 |
| Adrian, TE; Arnelo, U; Ding, X; Herrington, MK; Larsson, J; Marcusson, J; Permert, J; Reidelberger, R; Strömmer, L; Theodorsson, E | 1 |
| Antkiewicz-Michaluk, L; Herman, ZS; Obuchowicz, E; Romańska, I | 1 |
| Castro, WL; Delgado, PL; El Khoury, A; Mathé, AA; Misiaszek, J; Moreno, FA; Palmer, C; Parkinson, D; Wright, R | 1 |
| Brunetti, L; Chiavaroli, A; Di Nisio, C; Ferrante, C; Leone, S; Orlando, G; Recinella, L; Salvatori, R; Shohreh, R; Vacca, M | 1 |
1 review(s) available for homovanillic acid and neuropeptide y
| Article | Year |
|---|---|
Eating disorder research in the past decade.
Topics: Anorexia Nervosa; Body Image; Bulimia; Cognitive Behavioral Therapy; Family; Homovanillic Acid; Humans; Hypothalamus; Neuropeptide Y; Neurotransmitter Agents; Psychiatric Status Rating Scales; Research | 1996 |
1 trial(s) available for homovanillic acid and neuropeptide y
| Article | Year |
|---|---|
CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls.
Topics: Adult; Analysis of Variance; Case-Control Studies; Chromatography, High Pressure Liquid; Circadian Rhythm; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Electrochemistry; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Indoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurochemistry; Neuropeptide Y; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Tryptophan; Young Adult | 2010 |
14 other study(ies) available for homovanillic acid and neuropeptide y
| Article | Year |
|---|---|
Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Depressive Disorder; Dynorphins; Female; Galanin; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Recall; Methoxyhydroxyphenylglycol; Middle Aged; Neuropeptide Y; Neuropsychological Tests; Peptide Fragments; Peptides; Receptors, Opioid; Vasoactive Intestinal Peptide | 1991 |
The effect of neuropeptide Y on striatal catecholamines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Neuropeptide Y; Peptide YY; Peptides; Rats; Rats, Inbred Strains; Serotonin; Somatostatin | 1986 |
Neuropeptide Y potentiation of potassium-induced noradrenaline release in the hypothalamic paraventricular nucleus of the rat in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Basal Metabolism; Drug Synergism; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Neuropeptide Y; Norepinephrine; Paraventricular Hypothalamic Nucleus; Potassium; Rats; Rats, Sprague-Dawley; Stimulation, Chemical | 1995 |
Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Aging; Animals; Azides; Biogenic Amines; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Functional Laterality; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Homovanillic Acid; Injections, Intraperitoneal; Lactates; Magnetic Resonance Imaging; Male; Microinjections; NADPH Dehydrogenase; Neurons; Neuropeptide Y; Neuropeptides; Neurotoxins; Oxidative Phosphorylation; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sodium Azide; Somatostatin; Substance P | 1994 |
Neurochemical effects of neuropeptide Y (NPY) and NPY2-36.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; Neuropeptide Y; Norepinephrine; Peptide Fragments; Rats; Serotonin; Tissue Distribution | 1994 |
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Calbindins; Cell Adhesion Molecules, Neuronal; Corpus Striatum; Dopamine; Energy Metabolism; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Homovanillic Acid; Interneurons; Male; Mitochondria; NADPH Dehydrogenase; Neurons; Neuropeptide Y; Neurotoxins; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Reference Values; S100 Calcium Binding Protein G; Somatostatin; Substance P | 1993 |
Differential regulation of sympathetic neuron neuropeptide Y and catecholamine content and secretion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Bucladesine; Calcimycin; Catecholamines; Cells, Cultured; Colforsin; Dopamine; Electrochemistry; Female; Homeostasis; Homovanillic Acid; Immunohistochemistry; Kinetics; Neurons; Neuropeptide Y; Potassium; Pregnancy; Rats; Rats, Sprague-Dawley; Signal Transduction; Superior Cervical Ganglion; Tetradecanoylphorbol Acetate; Time Factors | 1995 |
Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children.
Topics: Adolescent; Biomarkers, Tumor; Child; Child, Preschool; Female; Homovanillic Acid; Humans; Infant; Male; Neuroblastoma; Neuropeptide Y; Phosphopyruvate Hydratase; Vanilmandelic Acid | 1993 |
The concentrations of monoamine metabolites and neuropeptides in the cerebrospinal fluid of obese women with different body fat distribution.
Topics: Adipose Tissue; Adult; beta-Endorphin; Biogenic Monoamines; Body Composition; Body Constitution; Body Mass Index; Corticotropin-Releasing Hormone; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Neuropeptide Y; Obesity | 1996 |
Effects of neuropeptide Y (NPY) and [D-Trp32]NPY on monoamine and metabolite levels in dialysates from rat hypothalamus during feeding behavior.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Biogenic Monoamines; Dopamine; Feeding Behavior; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothalamus; Male; Microdialysis; Neuropeptide Y; Norepinephrine; Rats; Rats, Wistar; Serotonin | 1996 |
Neuropeptide Y and [Leu31,Pro34]neuropeptide Y potentiate potassium-induced noradrenaline release in the paraventricular nucleus of the aged rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Cerebral Ventricles; Drug Synergism; Homovanillic Acid; Injections, Intraventricular; Male; Microdialysis; Neuropeptide Y; Norepinephrine; Paraventricular Hypothalamic Nucleus; Potassium; Rats; Rats, Sprague-Dawley; Time Factors | 1997 |
Effects of long-term infusion of anorexic concentrations of islet amyloid polypeptide on neurotransmitters and neuropeptides in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amyloid; Animals; Anorexia; Biogenic Monoamines; Blood Glucose; Brain; Cholecystokinin; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Infusions, Parenteral; Insulin; Islet Amyloid Polypeptide; Male; Methoxyhydroxyphenylglycol; Neuropeptide Y; Neuropeptides; Neurotensin; Norepinephrine; Rats; Rats, Wistar; Serotonin | 2000 |
Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Antagonists; Animals; Chromatography, High Pressure Liquid; Clonidine; Corpus Striatum; Dopamine; Homovanillic Acid; Immunohistochemistry; Levodopa; Male; Mice; MPTP Poisoning; Neuropeptide Y; Neuroprotective Agents; Selegiline; Serotonin | 2003 |
Effects of growth hormone-releasing hormone gene targeted ablation on ghrelin-induced feeding.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alleles; Animals; Chromatography, High Pressure Liquid; Eating; Female; Genotype; Ghrelin; Growth Hormone; Growth Hormone-Releasing Hormone; Homovanillic Acid; Homozygote; Hydroxyindoleacetic Acid; Hypothalamus; Male; Mice; Mice, Knockout; Neuropeptide Y | 2017 |